Brain Mets - Capecitabine Plus Sunitinib and WBRT
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: sunitinib|DRUG: capecitabine|RADIATION: WBRT
Sponsor: Baylor Breast Care Center